{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:08:37Z","timestamp":1776287317470,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1007\/bf01984054","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T01:38:06Z","timestamp":1123119486000},"page":"150-156","source":"Crossref","is-referenced-by-count":14,"title":["In vivo responses of mouse blood cells to platelet-activating factor (PAF): Role of the mediators of anaphylaxis"],"prefix":"10.1007","volume":"40","author":[{"given":"Dimitrios","family":"Kelefiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Vakirtzi-Lemonias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01984054_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0090-6980(85)90018-8","volume":"30","author":"J. M. Young","year":"1985","unstructured":"J. M. Young, P. J. Maloney, S. N. Jubb and J. S. Clark,Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. Prostaglandins30, 545\u2013551 (1985).","journal-title":"Prostaglandins"},{"key":"BF01984054_CR2","first-page":"123","volume":"308","author":"T. Yamada","year":"1990","unstructured":"T. Yamada, K. Tomioka, M. Saito, M. Horie, T. Mase, H. Hara and H. Nagaoka,Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor. Arch. Int. Pharmacodyn. Ther.308, 123\u2013136 (1990).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"BF01984054_CR3","first-page":"1201","volume":"40","author":"H. Tsunoda","year":"1990","unstructured":"H. Tsunoda, Y. Sakuma, K. Harada, K. Muramoto, S. Katayama, T. Horie, N. Shimomura, R. Clark, S. Miyazawa, K. Okano, Y. Machida, K. Katayama and I. Yamatsu,Pharmacological activities of novel thienodiazepine derivative as a platelet-activating factor antagonist. Arzneim.-forsch.\/Drug Res.40, 1201\u20131205 (1990).","journal-title":"Arzneim.-forsch.\/Drug Res."},{"key":"BF01984054_CR4","first-page":"44","volume":"259","author":"J. M. Herbet","year":"1991","unstructured":"J. M. Herbet, A. Bernat, G. Valette, V. Gigo, A. Lale, M. C. Laplace, L. Lespy, P. Savi, J. P. Maffrand and G. Le Fur,Biochemical and pharmacological activities of SR27417, a highly potent, long-acting platelet-activating factor receptor antagonist. J. Pharmacol. Exp. Ther.259, 44\u201351 (1991).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01984054_CR5","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/jm00089a016","volume":"35","author":"D. E. Guinn","year":"1992","unstructured":"D. E. Guinn, J. B. Summers, H. R. Heyman, R. G. Conway, D. A. Rhein, D. H. Albert, T. Magoc and G. W. Carter,Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet-activating factor antagonists. J. Med. Chem.35, 2055\u20132061 (1992).","journal-title":"J. Med. Chem."},{"key":"BF01984054_CR6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0006-291X(82)91897-6","volume":"109","author":"E. Lanara","year":"1982","unstructured":"E. Lanara, C. Vakirtzi-Lemonias, L. G. Kritikou and C. A. Demopoulos,Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine. Biochem. Biophys. Res. Commun.109, 1148\u20131156 (1982).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF01984054_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(88)90453-5","volume":"42","author":"D. Kelefiotis","year":"1987","unstructured":"D. Kelefiotis, E. Lanara, C. Vakirtzi-Lemonias, A. Siafaca, M. Mavris, M. Lazanas and C. A. Demopoulos,Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. Life Sci.42, 623\u2013633 (1987).","journal-title":"Life Sci."},{"key":"BF01984054_CR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(82)90234-1","volume":"25","author":"D. H. Namm","year":"1982","unstructured":"D. H. Namm, A. S. Taderalli and J. A. High,Species specificity of the platelet responses to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine. Thromb. Res.25, 341\u2013350 (1982).","journal-title":"Thromb. Res."},{"key":"BF01984054_CR9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0006-2952(85)90689-6","volume":"34","author":"Z.-I. Terashita","year":"1985","unstructured":"Z.-I. Terashita, Y. Imura and K. Nishikawa,Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Biochem. Pharmacol.34, 1491\u20131495 (1985).","journal-title":"Biochem. Pharmacol."},{"key":"BF01984054_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1981.tb29727.x","volume":"370","author":"B. B. Vargaftig","year":"1981","unstructured":"B. B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort and F. Wal,Background and present status of research on platelet-activating factor (PAF-acether). Ann. N.Y. Acad. Sci.370, 119\u2013137 (1981).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF01984054_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(84)90623-X","volume":"105","author":"P. Inarrea","year":"1984","unstructured":"P. Inarrea, J. Gomez-Cambronero, M. Nieto and M. Sancez Crespo,Characteristics of the binding of platelet-activating factor to platelets of different animal species. Eur. J. Pharmacol.105, 309\u2013315 (1984).","journal-title":"Eur. J. Pharmacol."},{"key":"BF01984054_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000229815","volume":"30","author":"E. T. Iff","year":"1966","unstructured":"E. T. Iff and N. M. Vaz,Mechanisms of anaphylaxis in the mouse: Similarity of shock induced by anaphylaxis and by mixtures of histamine and serotonin. Int. Arch. Allergy30, 313\u2013322 (1966).","journal-title":"Int. Arch. Allergy"},{"key":"BF01984054_CR13","first-page":"389","volume":"20","author":"B. N. Halpern","year":"1963","unstructured":"B. N. Halpern, T. Neveu and S. Spector,On the nature of the chemical mediators involved in anaphlyactic reactions in mice. Br. J. Pharmacol.20, 389\u2013398 (1963).","journal-title":"Br. J. Pharmacol."},{"key":"BF01984054_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(82)90373-9","volume":"78","author":"M. Chignard","year":"1982","unstructured":"M. Chignard, F. Wal, J. Lefort and B. B. Vargaftig,Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pig. Eur. J. Pharmacol.78, 71\u201379 (1982).","journal-title":"Eur. J. Pharmacol."},{"key":"BF01984054_CR15","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/S0021-9258(19)83523-8","volume":"254","author":"C. A. Demopoulos","year":"1979","unstructured":"C. A. Demopoulos, R. N. Pinckard and D. J. Hanahan,Platelte-activating factor. Evidence for 1-O-alkyl-2-acetylsn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem.254, 9355\u20139358 (1979).","journal-title":"J. Biol. Chem."},{"key":"BF01984054_CR16","first-page":"303","volume":"45","author":"L. M. McManus","year":"1981","unstructured":"L. M. McManus, R. N. Pinckard, F. A. Fitzpatrick, R. A. O'Rourke, M. H. Crawford and D. J. Hanahan,Acetyl glyceryl ether phosphorylcholine: Intravascular alterations following intravenous infusion into the baboon. Lab. Invest.45, 303\u2013307 (1981).","journal-title":"Lab. Invest."},{"key":"BF01984054_CR17","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4049\/jimmunol.124.6.2919","volume":"124","author":"L. M. McManus","year":"1980","unstructured":"L. M. McManus, D. J. Hanahan, C. A. Demopoulos and R. N. Pinckard,Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J. Immunol.124, 2919\u20132924 (1980).","journal-title":"J. Immunol."},{"key":"BF01984054_CR18","first-page":"133","volume":"3","author":"C. A. Demopoulos","year":"1981","unstructured":"C. A. Demopoulos, G. E. Tsabikakis and V. M. Kapoulas,Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs. Immunol. Lett.3, 133\u2013135 (1981).","journal-title":"Immunol. Lett."},{"key":"BF01984054_CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1042\/bst0140094","volume":"14","author":"D. Kelefiotis","year":"1986","unstructured":"D. Kelefiotis and C. Vakirtzi-Lemonias,Effect of non-steroidal anti-inflammatory drugs on alkyl-acetyl-glycerol-phosphocholine-induced anaphylactic shock in mice. Biochem. Soc. Trans.14, 94\u201395 (1986).","journal-title":"Biochem. Soc. Trans."},{"key":"BF01984054_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1983.tb11034.x","volume":"79","author":"A. Myers","year":"1983","unstructured":"A. Myers, E. Ramey and P. Ramwell,Glucocorticoid protection against PAF-acether toxicity in mice. Br. J. Pharmacol.79, 595\u2013598 (1983).","journal-title":"Br. J. Pharmacol."},{"key":"BF01984054_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1139\/y91-064","volume":"69","author":"L. Levesque","year":"1991","unstructured":"L. Levesque, R. C. Gaureault and F. Marceau,The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leucocytes: A study of structure-activity relationship. Can. J. Physiol. Pharmacol.69, 419\u2013425 (1991).","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01984054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01984054\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01984054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:34:21Z","timestamp":1683160461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01984054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":21,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["BF01984054"],"URL":"https:\/\/doi.org\/10.1007\/bf01984054","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}